Acumen Pharmaceuticals Inc (ABOS)
2.305
-0.06
(-2.74%)
USD |
NASDAQ |
Nov 21, 16:00
2.305
0.00 (0.00%)
After-Hours: 19:54
Acumen Pharmaceuticals Price: 2.305 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 2.42 | 2.45 | 2.32 | 2.37 | 180497.0 |
Nov 19, 2024 | 2.23 | 2.39 | 2.23 | 2.39 | 146848.0 |
Nov 18, 2024 | 2.40 | 2.455 | 2.24 | 2.24 | 225478.0 |
Nov 15, 2024 | 2.62 | 2.62 | 2.37 | 2.40 | 296509.0 |
Nov 14, 2024 | 2.57 | 2.66 | 2.41 | 2.61 | 202922.0 |
Nov 13, 2024 | 2.73 | 2.738 | 2.52 | 2.53 | 182300.0 |
Nov 12, 2024 | 3.20 | 3.20 | 2.55 | 2.675 | 431142.0 |
Nov 11, 2024 | 3.36 | 3.36 | 3.11 | 3.22 | 190218.0 |
Nov 08, 2024 | 3.19 | 3.29 | 3.15 | 3.27 | 160391.0 |
Nov 07, 2024 | 3.23 | 3.29 | 3.16 | 3.17 | 179514.0 |
Nov 06, 2024 | 3.02 | 3.295 | 2.85 | 3.23 | 392769.0 |
Nov 05, 2024 | 2.96 | 3.02 | 2.95 | 3.00 | 106271.0 |
Nov 04, 2024 | 2.84 | 3.05 | 2.790 | 2.95 | 198629.0 |
Nov 01, 2024 | 2.89 | 2.94 | 2.79 | 2.845 | 104417.0 |
Oct 31, 2024 | 3.04 | 3.04 | 2.85 | 2.88 | 158134.0 |
Oct 30, 2024 | 2.90 | 3.14 | 2.84 | 3.03 | 244561.0 |
Oct 29, 2024 | 2.95 | 2.95 | 2.75 | 2.905 | 201944.0 |
Oct 28, 2024 | 3.00 | 3.14 | 2.87 | 2.89 | 274061.0 |
Oct 25, 2024 | 2.75 | 3.03 | 2.75 | 2.90 | 299452.0 |
Oct 24, 2024 | 2.71 | 2.75 | 2.68 | 2.74 | 65908.00 |
Oct 23, 2024 | 2.79 | 2.850 | 2.60 | 2.69 | 121385.0 |
Oct 22, 2024 | 2.69 | 2.82 | 2.64 | 2.80 | 164888.0 |
Oct 21, 2024 | 2.85 | 2.95 | 2.64 | 2.70 | 180857.0 |
Oct 18, 2024 | 2.70 | 2.885 | 2.670 | 2.86 | 289716.0 |
Oct 17, 2024 | 2.40 | 2.66 | 2.38 | 2.66 | 1.004M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.86
Minimum
Nov 09 2023
20.28
Maximum
Jul 02 2021
5.884
Average
4.96
Median
Jul 03 2023
Price Benchmarks
Kodiak Sciences Inc | 5.915 |
NovaBay Pharmaceuticals Inc | 0.718 |
Palatin Technologies Inc | 0.91 |
iBio Inc | 2.45 |
Theriva Biologics Inc | 1.28 |
Price Related Metrics
Price to Book Value | 0.6376 |
Earnings Yield | -59.87% |
Market Cap | 138.48M |